On Oct. 1, 2024, the American Cancer Society (ACS) released Breast Cancer Statistics, 2024, the organization’s biennial update…
On Sept. 24, 2024, researchers at the National Institutes of Health (NIH) reported results of a study that…
On Sept. 18, 2024, researchers from the Wellcome Sanger Institute and their collaborators reported that they had identified…
On Nov. 13, 2020, Agilent Technologies announced it had received U.S. Food and Drug Administration (FDA) approval for…
On Nov. 13, 2020, Merck announced that the U.S. Food and Drug Administration (FDA) had approved KEYTRUDA, Merck’s…
On Jan. 11, 2016, the U.S. Preventive Services Task Force (USPSTF) recommended biennial screening mammography for women aged…
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
On May. 13, 2008, the Breast Cancer and Environmental Research Act of 2007 amended the Public Health Service…
In 2008, the Seattle Cancer Care Alliance introduced the Mammovan, making digital mammography more accessible to women throughout…
On Dec. 12, 2007, the Breast Cancer Research Stamp Reauthorization Act extended through Dec. 31, 2011, provisions requiring…
On Apr. 20, 2007, the National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007 allowed…
On Mar. 28, 2007, Magnetic Resonance Imaging (MRI) scans of women who were diagnosed with cancer in one…
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
On Nov. 11, 2005, the U.S. Congress authorized the 2-year extension of Postage Stamp for Breast Cancer Research…
On Dec. 12, 2002, a National Cancer Institute announced that a clinical trial had shown that reducing the…
On Nov. 12, 2001, the President George W. Bush signed P.L. 107-67 making appropriations for the Treasury Department,…
On Jul. 28, 2000, President Bill Clinton signed into law the Semipostal Authorization Act (P.L. 106-253), which gave…
In 1999, Siteman Cancer Center investigators joined the STAR (Study of Tamoxifen and Raloxifene) trial for breast cancer…
On Sept. 14, 1998, researchers from the Breast Cancer Prevention Trial (BCPT) published a full report and update…
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
On Aug. 13, 1997, the Stamp Out Breast Cancer Act (PL 105-41) was signed into law by President…
In August 1997, the U.S. Congress passed legislation that directed the U.S. Postal Service to issue its first…
In 1995, Mary-Claire King, an internationally known human geneticist, was recruited to the University of Washington’s (UW) School…
In 1995, scientists cloned the tumor suppressor genes BRCA1 and BRCA2, inherited genetic mutations that can predict an…
In 1995, The BRCA2 gene was mapped to chromosomal 13q. Just fifteen months later, Wooster et al.5 reported…
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate,…
On Oct. 27, 1992, the Mammography Quality Standards Act (MQSA) was passed (P.L. 102-539) by the U.S. Congress….
In 1991, the U.S. Centers for Disease Control and Prevention (CDC) began developing a national strategic plan for…
In 1989, Karmanos Cancer Institute researcher Dr. Soule developed MCF-10, an immortal line of normal human breast cells….